Insider Transactions in Q3 2022 at Larimar Therapeutics, Inc. (LRMR)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2022
|
Thomas Edward Hamilton Director |
BUY
Open market or private purchase
|
Direct |
317,460
+38.48%
|
$952,380
$3.15 P/Share
|
|
Sep 16
2022
|
James E Flynn Director |
BUY
Open market or private purchase
|
Indirect |
11,111,108
+40.28%
|
$33,333,324
$3.15 P/Share
|
|
Sep 16
2022
|
Michael Celano Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
31,746
+50.0%
|
$95,238
$3.15 P/Share
|
|
Sep 16
2022
|
Carole Ben Maimon President and CEO |
BUY
Open market or private purchase
|
Direct |
31,746
+35.84%
|
$95,238
$3.15 P/Share
|